{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:44:16Z","timestamp":1786985056602,"version":"build-2736575974"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.bbrc.2024.151195","type":"journal-article","created":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T20:57:30Z","timestamp":1734209850000},"page":"151195","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Hydroxycinnamic acids mediated modulation of \u03b1-Synuclein fibrillation: Biophysical insights"],"prefix":"10.1016","volume":"744","author":[{"family":"Tinku","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1679-8099","authenticated-orcid":false,"given":"Sinjan","family":"Choudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.bbrc.2024.151195_bib1","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1515\/CCLM.2001.172","article-title":"Protein aggregation","volume":"39","author":"Merlini","year":"2001","journal-title":"Clin. Chem. Lab. Med."},{"issue":"3","key":"10.1016\/j.bbrc.2024.151195_bib2","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/00005072-199603000-00001","article-title":"Neuropathology of Parkinson's disease","volume":"55","author":"Forno","year":"1996","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.bbrc.2024.151195_bib3","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.ijbiomac.2021.05.071","article-title":"Modulation of \u03b1-synuclein fibrillation by plant metabolites, daidzein, fisetin and scopoletin under physiological conditions","volume":"182","author":"Rane","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bbrc.2024.151195_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.2003.tb07458.x","article-title":"Description of Parkinson's disease as a clinical syndrome","volume":"991","author":"Fahn","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bbrc.2024.151195_bib5","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.ijbiomac.2019.09.053","article-title":"Natural compound safranal driven inhibition and dis-aggregation of \u03b1-synuclein fibrils","volume":"141","author":"Save","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bbrc.2024.151195_bib6","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3389\/fbioe.2020.00112","article-title":"Antioxidant Nanoparticles for Concerted Inhibition of \u03b1-Synuclein Fibrillization, and Attenuation of Microglial Intracellular Aggregation and Activation","volume":"8","author":"Zhao","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.bbrc.2024.151195_bib7","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev.neuro.22.1.123","article-title":"Etiology and pathogenesis of Parkinson's disease","volume":"22","author":"Olanow","year":"1999","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.bbrc.2024.151195_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2023.117529","article-title":"4-Arylidene curcumin derivatives in vitro inhibit \u03b1-Synuclein aggregation and disaggregate the preformed fibril","volume":"96","author":"Liu","year":"2023","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bbrc.2024.151195_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2021.116105","article-title":"Title of the manuscript: mechanistic insights into chalcone butein-induced inhibition of \u03b1-synuclein fibrillation: Biophysical and insilico studies","volume":"334","author":"Tinku","year":"2021","journal-title":"J. Mol. Liq."},{"issue":"6","key":"10.1016\/j.bbrc.2024.151195_bib10","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.neuron.2013.09.004","article-title":"The function of \u03b1-synuclein","volume":"79","author":"Bendor","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.bbrc.2024.151195_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2023.129564","article-title":"The potential of Rhein's aromatic amines for Parkinson's disease prevention and treatment: \u03b1-Synuclein aggregation inhibition and disaggregation of preformed fibers","volume":"97","author":"Zhang","year":"2024","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"10","key":"10.1016\/j.bbrc.2024.151195_bib12","doi-asserted-by":"crossref","first-page":"12262","DOI":"10.1021\/acsomega.4c00595","article-title":"Understanding the modulation of \u03b1-synuclein fibrillation by N-acetyl aspartate: a brain metabolite","volume":"9","author":"Khan","year":"2024","journal-title":"ACS Omega"},{"key":"10.1016\/j.bbrc.2024.151195_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2024.129752","article-title":"In vitro inhibition of \u03b1-Synuclein aggregation and disaggregation of preformed fibers by polyphenol hybrids with 2-conjugated benzothiazole","volume":"105","author":"Zhao","year":"2024","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"12","key":"10.1016\/j.bbrc.2024.151195_bib14","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.3390\/biomedicines10123241","article-title":"Synucleins: new data on misfolding, aggregation and role in diseases","volume":"10","author":"Surguchov","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.bbrc.2024.151195_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116198","article-title":"Pyrazolamide derivatives inhibit \u03b1-Synuclein aggregation, disaggregate preformed fibers, and reduce inclusion formation in neuron cells","volume":"268","author":"Xing","year":"2024","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bbrc.2024.151195_bib16","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3164\/jcbn.D-11-00030","article-title":"Cytoprotective effect of chlorogenic acid against \u03b1-synuclein-related toxicity in catecholaminergic PC12 cells","volume":"51","author":"Teraoka","year":"2012","journal-title":"J. Clin. Biochem. Nutr."},{"key":"10.1016\/j.bbrc.2024.151195_bib17","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1096\/fj.08-119784","article-title":"Structural insights on physiological functions and pathological effects of \u03b1-synuclein","volume":"23","author":"Bisaglia","year":"2009","journal-title":"Faseb. J."},{"key":"10.1016\/j.bbrc.2024.151195_bib18","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.bbapap.2017.02.014","article-title":"Polyphenols in combination with b-cyclodextrin can inhibit and disaggregate \u03b1-synuclein amyloids under cell mimicking conditions: a promising therapeutic alternative","volume":"1865","author":"Gautam","year":"2017","journal-title":"Biochim. Biophys. Acta, Proteins Proteomics"},{"key":"10.1016\/j.bbrc.2024.151195_bib19","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1096\/fj.03-1346fje","article-title":"A strategy for designing inhibitors of alpha-synuclein aggregation and toxicity as a novel treatment for Parkinson's disease and related disorders","volume":"18","author":"El-Agnaf","year":"2004","journal-title":"Faseb. J."},{"issue":"5","key":"10.1016\/j.bbrc.2024.151195_bib20","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1073\/pnas.0407146102","article-title":"Release of long-range tertiary interactions potentiates aggregation of natively unstructured alpha-synuclein","volume":"102","author":"Bertoncini","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2024.151195_bib21","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.3389\/fphar.2018.01555","article-title":"Plant extracts and phytochemicals targeting \u03b1-synuclein aggregation in Parkinson's disease models","volume":"9","author":"Javed","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"22","key":"10.1016\/j.bbrc.2024.151195_bib22","doi-asserted-by":"crossref","first-page":"3763","DOI":"10.2174\/092986712801661112","article-title":"Structure and ligand-based drug design strategies in the development of novel 5- LOX inhibitors","volume":"19","author":"Aparoy","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bbrc.2024.151195_bib23","article-title":"Structure-based inhibitor design for the intrinsically disordered protein c-myc","volume":"6","author":"Yu","year":"2016","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.bbrc.2024.151195_bib24","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.tibtech.2006.07.005","article-title":"Rational drug design via intrinsically disordered protein","volume":"24","author":"Cheng","year":"2006","journal-title":"Trends Biotechnol."},{"issue":"4","key":"10.1016\/j.bbrc.2024.151195_bib25","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1177\/1715163518779409","article-title":"Patients' perceptions and use of natural health products","volume":"151","author":"Barry","year":"2018","journal-title":"Can. Pharm. J."},{"issue":"9","key":"10.1016\/j.bbrc.2024.151195_bib26","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1093\/chromsci\/bmv060","article-title":"Ultra-performance liquid chromatography for the simultaneous quantification of rutin and chlorogenic acid in leaves of Ribes L. species by conventional and chemometric calibration approaches","volume":"53","author":"Kendir","year":"2015","journal-title":"J. Chromatogr. Sci."},{"key":"10.1016\/j.bbrc.2024.151195_bib27","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.foodchem.2015.03.086","article-title":"Chlorogenic acid-arabinose hybrid domains in coffee melanoidins: evidence from a model system","volume":"185","author":"Moreira","year":"2015","journal-title":"Food Chem."},{"issue":"3","key":"10.1016\/j.bbrc.2024.151195_bib28","doi-asserted-by":"crossref","first-page":"216","DOI":"10.2174\/1570159X17666191021111809","article-title":"Pharmacologic overview of chlorogenic acid and its metabolites in chronic pain and inflammation","volume":"18","author":"Bagdas","year":"2020","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.bbrc.2024.151195_bib29","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.lfs.2015.01.036","article-title":"Involvement of TLR2 and TLR9 in the anti-inflammatory effects of chlorogenic acid in HSV-1-infected microglia","volume":"127","author":"Guo","year":"2015","journal-title":"Life Sci."},{"issue":"5","key":"10.1016\/j.bbrc.2024.151195_bib30","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1007\/s12272-013-0050-5","article-title":"Effect of sinapic acid against carbon tetrachloride-induced acute hepatic injury in rats","volume":"36","author":"Shin","year":"2013","journal-title":"Arch Pharm. Res. (Seoul)"},{"issue":"2","key":"10.1016\/j.bbrc.2024.151195_bib31","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1039\/B916096E","article-title":"Antimicrobial natural products: an update on future antibiotic drug candidates","volume":"27","author":"Saleem","year":"2010","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.bbrc.2024.151195_bib32","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/3571614","article-title":"Sinapic acid and its derivatives as medicine in oxidative stress-induced diseases and aging","volume":"2016","author":"Chen","year":"2016","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.bbrc.2024.151195_bib33","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.foodchem.2008.08.086","article-title":"Chlorogenic acids and related compounds in medicinal plants and infusions","volume":"113","author":"Marques","year":"2009","journal-title":"Food Chem."},{"key":"10.1016\/j.bbrc.2024.151195_bib34","doi-asserted-by":"crossref","first-page":"6419","DOI":"10.1021\/bi5010365","article-title":"The newly discovered Parkinson's disease associated Finnish mutation (A53E) attenuates \u03b1-synuclein aggregation and membrane binding","volume":"53","author":"Ghosh","year":"2014","journal-title":"Biochemistry"},{"issue":"52","key":"10.1016\/j.bbrc.2024.151195_bib35","doi-asserted-by":"crossref","DOI":"10.1039\/C7RA03752J","article-title":"(\u2212)-Epigallocatechin-3-gallate (EGCG) inhibits fibrillation, disaggregates amyloid fibrils of \u03b1-synuclein, and protects PC12 cells against \u03b1-synuclein-induced toxicity","volume":"7","author":"Zhao","year":"2017","journal-title":"RSC Adv."},{"key":"10.1016\/j.bbrc.2024.151195_bib36","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1017\/S0033583517000026","article-title":"Unraveling amyloid formation paths of Parkinson's disease protein \u03b1-synuclein triggered by anionic vesicles","volume":"50","author":"Kiskis","year":"2017","journal-title":"Q. Rev. Biophys."},{"key":"10.1016\/j.bbrc.2024.151195_bib37","series-title":"CRC Handbook of Chemistry and Physics","author":"Goldberg","year":"2002"},{"key":"10.1016\/j.bbrc.2024.151195_bib38","doi-asserted-by":"crossref","first-page":"9595","DOI":"10.1074\/jbc.M411805200","article-title":"Structure and dynamics of micelle-bound human alpha-synuclein","volume":"280","author":"Ulmer","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.bbrc.2024.151195_bib39","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/protein\/8.2.127","article-title":"LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions","volume":"8","author":"Wallace","year":"1995","journal-title":"Protein Eng."},{"issue":"10","key":"10.1016\/j.bbrc.2024.151195_bib40","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1021\/ci200227u","article-title":"LigPlot+: multiple ligand-protein interaction diagrams for drug discovery","volume":"51","author":"Laskowski","year":"2011","journal-title":"J. Chem. Inf. Model."},{"issue":"4","key":"10.1016\/j.bbrc.2024.151195_bib41","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jff.2011.05.005","article-title":"The ability of gallate and pyrogallol moieties of catechins to inhibit P-glycoprotein function","volume":"3","author":"Sugihara","year":"2011","journal-title":"J. Funct.Foods"},{"issue":"14","key":"10.1016\/j.bbrc.2024.151195_bib42","doi-asserted-by":"crossref","first-page":"5540","DOI":"10.3390\/molecules28145540","article-title":"Risk assessment of chlorogenic and isochlorogenic acids in coffee by-products","volume":"28","author":"Behne","year":"2023","journal-title":"Molecules"},{"issue":"21","key":"10.1016\/j.bbrc.2024.151195_bib43","doi-asserted-by":"crossref","first-page":"11273","DOI":"10.1021\/jf103075r","article-title":"Dietary phenolic acids and derivatives. Evaluation of the antioxidant activity of sinapic acid and its alkyl esters","volume":"58","author":"Gaspar","year":"2010","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.bbrc.2024.151195_bib44","doi-asserted-by":"crossref","first-page":"16462","DOI":"10.1074\/jbc.C300049200","article-title":"Direct observation of amyloid fibril growth monitored by thioflavin T fluorescence","volume":"278","author":"Ban","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"20","key":"10.1016\/j.bbrc.2024.151195_bib45","doi-asserted-by":"crossref","first-page":"6036","DOI":"10.1021\/bi002555c","article-title":"Effect of environmental factors on the kinetics of insulin fibril formation: elucidation of the molecular mechanism","volume":"40","author":"Nielsen","year":"2001","journal-title":"Biochemistry"},{"issue":"4","key":"10.1016\/j.bbrc.2024.151195_bib46","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s12551-016-0218-6","article-title":"Dynamic light scattering: a practical guide and applications in biomedical sciences","volume":"8","author":"Stetefeld","year":"2016","journal-title":"Biophys. Rev."},{"key":"10.1016\/j.bbrc.2024.151195_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103957","article-title":"Interaction of an abiraterone with calf thymus DNA: investigation with spectroscopic technique and modeling studies","volume":"100","author":"Wani","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bbrc.2024.151195_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.saa.2020.118335","article-title":"Poziotinib and bovine serum albumin binding characterization and influence of quercetin, rutin, naringenin, and sinapic acid on their binding interaction","volume":"235","author":"Zargar","year":"2020","journal-title":"Spectrochim. Acta Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.bbrc.2024.151195_bib49","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.2147\/DDDT.S169697","article-title":"Spectroscopic and molecular modeling studies of the binding interaction between bovine serum albumin and roflumilast","volume":"12","author":"Wani","year":"2018","journal-title":"Drug Des. Dev. Ther."},{"issue":"2","key":"10.1016\/j.bbrc.2024.151195_bib50","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/protein\/8.2.127","article-title":"LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions","volume":"8","author":"Wallace","year":"1995","journal-title":"Protein Eng."},{"issue":"10","key":"10.1016\/j.bbrc.2024.151195_bib51","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1021\/ci200227u","article-title":"LigPlot+: multiple ligand-protein interaction diagrams for drug discovery","volume":"51","author":"Laskowski","year":"2011","journal-title":"J. Chem. Inf. Model."},{"issue":"3","key":"10.1016\/j.bbrc.2024.151195_bib52","doi-asserted-by":"crossref","first-page":"177","DOI":"10.5599\/admet.1022","article-title":"Drug-like properties and fraction lipophilicity index as a combined metric","volume":"9","author":"Tsantili-Kakoulidou","year":"2021","journal-title":"ADMET DMPK"},{"issue":"4","key":"10.1016\/j.bbrc.2024.151195_bib53","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1602\/neurorx.2.4.541","article-title":"Medicinal chemical properties of successful central nervous system drugs","volume":"2","author":"H. Pajouhesh","year":"2005","journal-title":"NeuroRx"},{"issue":"14","key":"10.1016\/j.bbrc.2024.151195_bib54","doi-asserted-by":"crossref","first-page":"5540","DOI":"10.3390\/molecules28145540","article-title":"Risk assessment of chlorogenic and isochlorogenic acids in coffee by-products","volume":"28","author":"Behne","year":"2023","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.bbrc.2024.151195_bib55","doi-asserted-by":"crossref","DOI":"10.1098\/rsos.160696","article-title":"Thioflavin T as an amyloid dye: fibril quantification, optimal concentration, and effect on aggregation","volume":"4","author":"Xue","year":"2017","journal-title":"R. Soc. Open Sci."},{"issue":"10","key":"10.1016\/j.bbrc.2024.151195_bib56","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.4155\/fmc-2017-0016","article-title":"\u03b1-Synuclein aggregation modulation: an emerging approach for the treatment of Parkinson's disease","volume":"9","author":"Singh","year":"2017","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.bbrc.2024.151195_bib57","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.36402","article-title":"Cryo-EM structure of alpha-synuclein fibrils","volume":"7","author":"Guerrero-Ferreira","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.bbrc.2024.151195_bib58","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.ijbiomac.2017.07.185","article-title":"A mechanistic insight into protein-ligand interaction, folding, misfolding, aggregation and inhibition of protein aggregates","volume":"106","author":"Chandel","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.bbrc.2024.151195_bib59","doi-asserted-by":"crossref","first-page":"18","DOI":"10.4161\/idp.26255","article-title":"Biophysical characterization of \u03b1-synuclein and its controversial structure","volume":"1","author":"Alderson","year":"2013","journal-title":"Intrinsically Disord. Proteins"},{"key":"10.1016\/j.bbrc.2024.151195_bib60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003537","article-title":"Cross seeding of misfolded proteins: implications for etiology and pathogenesis of protein misfolding diseases","volume":"9","author":"Morales","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.bbrc.2024.151195_bib61","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1146\/annurev.biochem.66.1.385","article-title":"Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins","volume":"66","author":"Harper","year":"1997","journal-title":"Annu. Rev. Biochem."},{"issue":"45","key":"10.1016\/j.bbrc.2024.151195_bib62","doi-asserted-by":"crossref","first-page":"11827","DOI":"10.1021\/acs.langmuir.6b02572","article-title":"\u03b1-Synuclein oligomers stabilize pre-existing defects in supported bilayers and propagate membrane damage in a fractal-like pattern","volume":"32","author":"Chaudhary","year":"2016","journal-title":"Langmuir"},{"issue":"11","key":"10.1016\/j.bbrc.2024.151195_bib63","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s11910-014-0495-z","article-title":"Prion-like mechanisms in the pathogenesis of tauopathies and synucleinopathies","volume":"14","author":"Goedert","year":"2014","journal-title":"Curr. Neurol. Neurosci. Rep."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X24017315?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X24017315?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T10:59:19Z","timestamp":1735642759000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X24017315"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":63,"alternative-id":["S0006291X24017315"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2024.151195","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hydroxycinnamic acids mediated modulation of \u03b1-Synuclein fibrillation: Biophysical insights","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2024.151195","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"151195"}}